Dental Laboratory Welders Market Size Is Anticipated To Reach USD 264.8 Million by 2028

 Dental Laboratory Welders Market Growth & Trends

The global dental laboratory welders market size is anticipated to reach USD 264.8 million by 2028, according to the new report of Grand View Research, Inc. The market is expected to expand at a CAGR of 8.9% from 2021 to 2028. Dental laboratory welders are an essential tool as it assists in joining various types of pieces, made of similar or different alloys, such as titanium-based alloys, Cobalt-chromium (CoCr) alloys, and even gold-palladium (AuPd) alloys. It is an efficient and low-error alternative to the traditional soldering and brazing technique.

Factors like rising technological advancement in dental treatment and the high success rate of laser welding techniques in orthodontic procedures are propelling the market growth. According to the Dental Economic, the dental laser welding technique is currently the most advanced and high precision technique as compared to traditional welding. These advanced techniques provide the intra-oral ability for treatment, reduces distortion, provide high mechanical strength, and are corrosion resistant. Therefore the adoption of dental welding has increased by many professionals.

Dental welding is required for procedures like dental clasp assembly, cast repair, welding of the implant post, crown and bridge fixation, and other implant restoration procedures. According to the American Dental Association, around 5,000,000 implant procedures are carried out in the U.S alone with a success rate of 95%, rising success rate of implants and efficiency of welding techniques are some of the reasons for market growth.

In the light of COVID-19, the global market was hampered as the footfall of patient appointments for surgical treatments was temporarily suspended. However since the government in many countries has allowed resuming elective surgical procedures, clinics have also started orthodontic procedures again by adhering to strict Covid-19 protocols. Moreover, many dentists believe that there will be a surge for oral care and dental treat after the Covid-19 crisis and this is expected to propel market growth.

Request a free sample copy or view report summary: Dental Laboratory Welders Market Report

Dental Laboratory Welders Market Report Highlights

• By type, the manual segment held the largest revenue share in 2020 as these are the standard and efficient welding devices that are used by dentists. Technological advancement in manual welding devices like AI-enabled user interface and different pulse modes are expected to propel the segmental market further
• Based on application, the new clasp assembly segment accounted for the largest revenue share in 2020 as this procedure requires welding at different arms and welding is a prerequisite before implantation of clasps
• North America dominated the market with the highest revenue share in 2020 as the region has a high awareness of such procedure and there is high adoption by dentists
• In Asia Pacific, the market is bound to grow significantly in the forecast period owing to technological advancements and the rising number of the trained dentists

Access Press Release@ https://www.grandviewresearch.com/press-release/global-dental-laboratory-welders-market

Dental Laboratory Welders Market Segmentation

Grand View Research has segmented the global dental laboratory welders market on the basis of type, application, and region:

Dental Laboratory Welders Type Outlook (Revenue, USD Million, 2016 - 2028)

• Manual
• Automatic

Dental Laboratory Welders Application Outlook (Revenue, USD Million, 2016 - 2028)

• Cast Repairs
• New Clasp Assembly
• Loops & Posts for Implants
• Wrought Wire Single-Arm Clasping
• Crown & Bridge Cases
• Implant Restorations

Dental Laboratory Welders Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
• Latin America
  • Mexico
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Dental Laboratory Welders Market

• LaserStar
• Sunstone Engineering LLC
• Primotec
• Elettrolaser
• IPG photonics
• Max Photonics
• Alpha Laser

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Women’s Digital Health Market Size Is Expected To Reach USD 6.5 Billion by 2028

 Women’s Digital Health Market Growth & Trends

The global women’s digital health market size is expected to reach USD 6.5 billion by 2028, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 19.9% from 2021 to 2028. The encouraging regulatory environment for digital solutions catering to women’s fitness issues is expected to drive the growth of the market. In addition, the rise in funding for women’s health start-ups is one of the key growth factors as the investors are now attracted to this market.

The regulatory agencies have approved digital health applications specifically focusing on women's care. For instance, the FDA approved Ava, a fertility tracking wearable device and mobile application developed by Natural Cycles, as a class-one medical device in 2016. Ava received CE approval as a class-two medical device in 2017.

Women’s healthcare is gradually moving beyond reproductive health. Breast cancer, cardiovascular diseases, cervical cancer, maternal mortality, and mental diseases significantly contribute to the burden of women’s health issues. The government and various private organizations are now focusing on women’s fitness particularly and developing prominent solutions to address the issues.

The Covid-19 pandemic has reshaped the healthcare scenario as many countries implemented tough lockdown and millions of women living in developing/underdeveloped countries were unable to access required maternal care and contraceptives. In some countries, reproductive health issues were classified as non-essential services during the pandemic. Therefore, the implementation of digital fitness solutions such as mobile apps and wearable tracking devices witnessed significant growth in 2020.

Request a free sample copy or view report summary: Women’s Digital Health Market Report

Women’s Digital Health Market Report Highlights

• The mobile apps segment held a majority of the market share in 2020 owing to the rising adoption of mobile apps for the management of menstrual cycles, fertility cycles, and pregnancy
• On the other hand, the wearable device segment is likely to witness the fastest growth over the forecast period as they enable women to track their fitness parameters, menstrual cycles, ovulation, physical activities, heart rate, and sleep patterns
• The reproductive health segment accounted for a majority of the market share in 2020 pertaining to the highest adoption rate of mobile applications catering to female care management
• In 2020, North America held a majority of the regional market share owing to the availability of advanced technological infrastructure, better access to the latest devices, better reach for diagnosis and treatment, among many other factors. Asia Pacific is expected to witness the fastest growth over the forecast period from 2021 to 2028
• The market players are capitalizing on the opportunities by developing solutions to cater to the special areas of women’s healthcare. The established players focus on extensive R&D activities. Therefore, the start-up companies are constantly under pressure to introduce customizable user-friendly solutions in the market to keep their position in the market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-women-digital-health-market

Women’s Digital Health Market Segmentation

Grand View Research has segmented the global women’s digital health market based on type, application, and region:

Women’s Digital Health Type Outlook (Revenue, USD Million, 2016 - 2028)

• Mobile Apps
• Wearable Devices
• Diagnostic Tools
• Others

Women’s Digital Health Application Outlook (Revenue, USD Million, 2016 - 2028)

• Reproductive Health
• Pregnancy & Nursing Care
• Pelvic Care
• General Healthcare & Wellness

Women’s Digital Health Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

List of Key Players of Women’s Digital Health Market

• HeraMED
• iSono Health
• Clue by Biowink
• Chiaro Technology Ltd.
• Natural Cycles
• Ava Science, Inc.
• NURX Inc.
• Prima-Temp, Inc.
• Glow
• Lucina Health
• MobileODT Ltd.
• Braster SA
• Athena Feminine Technologies
• Plackal Tech

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

North America Savory Snacks Market Growth in the Coming Years

 North America Savory Snacks Market Growth & Trends

The North America savory snacks market size is expected to reach USD 59.25 billion by 2028, registering a CAGR of 6.1% over the forecast period, according to a new report by Grand View Research, Inc. Growing consumer emphasis on nutritional properties of the product, such as high vitamin & protein content with low calories, is expected to be a major factor contributing to the growth of the market. The rising demand for on-the-go snacks and increasing spending capacities of customers are projected to boost product demand. Several food trends, such as the growing vegan population, rising cases of lactose intolerance, and high demand for healthy snacks are driving the regional market. Consumers have also been increasing their spending on plant-based products as a result of the increased prevalence of certain health conditions including milk allergies.

According to the data provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), more than 80 million cases of lactose intolerance were recorded in 2019. According to the statistics provided by Food Allergy Research & Education, in 2019, an estimated 32 million Americans were suffering from food allergies. Thus, increasing cases of allergies and intolerance among adults as well as children are fueling the demand for vegan and healthy savory snack products. The market is highly fragmented owing to the presence of a large number of regional as well as international players. Key manufacturers adopt various strategies like product launches and mergers & acquisitions to enhance their foothold in the market.

Request a free sample copy or view report summary: North America Savory Snacks Market Report

North America Savory Snacks Market Report Highlights

• The potato chips segment led the market in 2020 and is anticipated to retain the dominance over the forecast period
• Nuts & seeds are anticipated to be the fastest-growing product segment from 2021 to 2028. Nuts & seeds are becoming increasingly popular as consumers are looking for healthy snacking options
• Roasted/toasted savory snacks was the largest flavor segment with a market share of more than 36% in 2020
• The segment is anticipated to remain dominant during the forecast period due to high product demand
• The spice flavor segment is anticipated to register the fastest CAGR from 2021 to 2028

Access Press Release@ https://www.grandviewresearch.com/press-release/north-america-savory-snacks-market-analysis

North America Savory Snacks Market Segmentation

Grand View Research has segmented the North America savory snacks market on the basis of product, flavors, distribution channel, and country:

North America Savory Snacks Product Outlook (Revenue, USD Million, 2016 -2028)

• Potato Chips
• Extruded Snacks
• Nuts & Seeds
• Popcorn
• Others

North America Savory Snacks Flavors Outlook (Revenue, USD Million, 2016 -2028)

• Roasted/Toasted
• Barbeque
• Spice
• Meat
• Others

North America Savory Snacks Distribution Channel Outlook (Revenue, USD Million, 2016 -2028)

• Supermarket/Hypermarket
• Specialty Retailers
• Convenience Stores
• Online
• Others

North America Savory Snacks Country Outlook (Revenue, USD Million, 2016 -2028)

• North America
  • US.
  • Canada
  • Mexico

List of Key Players of North America Savory Snacks Market

• PepsiCo, Inc.
• The Kraft Heinz Company
• Conagra Brands, Inc.
• Calbee, Inc.
• General Mills, Inc.
• Campbell Soup Company
• Arca Continental S.A.B. de C.V.
• Kellogg Company
• The Hain Celestial Group, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Europe Reusable Water Bottle Market To Hold a High Potential for Growth by 2028: Grand View Research Inc.

 Europe Reusable Water Bottle Market Growth & Trends

The Europe reusable water bottle market size is expected to reach USD 2.36 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.1% from 2021 to 2028. The increasing threat of plastic pollution, coupled with the severe environmental consequences of single-use and disposable water bottles, is propelling the demand for reusable bottles. An average reusable bottle ranges from USD 5 to USD 10. An average plastic bottle costs around USD 1 but could range up to USD 3 depending on the type. Although plastic bottles are cheaper per bottle, they are much more expensive in the long run, both in terms of individual spending and environmental degradation.

Consumers across the region are increasingly opting for reusable water bottles at workplaces, colleges, schools, and homes. These reusable bottles reduce the plastic burden on landfills, the main cause of groundwater pollution. Moreover, the growing awareness regarding the harmful environmental effects of disposable and single-use plastic bottles, along with a significant increase in plastic waste in oceans and landfills, is promoting the use of reusable water bottles.

According to the statistics provided as part of Beat Plastic Pollution, a UN Environment Program, around one million plastic drinking bottles are purchased every minute across the globe. These bottles are mainly responsible for the large-scale plastic pollution across the oceans and landfills. The same source also indicated that approximately 348 million tons of plastic are generated across the globe every year. Europe accounts for 60 million tons, about half of which gets thrown away and only about 30% of that waste is recycled.

Reusable stainless steel water bottles have become a popular choice among consumers owing to their temperature control attributes. The metal is capable of retaining the temperature of hot or cold water as desired. The insulated design of steel bottles has been widely appreciated by consumers. In addition to positive customer feedback, the FDA’s declaration on the safety of stainless steel has driven manufacturers to introduce these products in trendy and user-friendly designs.

E-commerce is becoming popular as the most preferred distribution channel owing to the high convenience associated with it. Customers are buying these bottles through online portals as a wide range of products is available. In addition, in the wake of the COVID-19 pandemic, consumers have refrained from physical shopping and largely opted for online purchases. This scenario has driven the manufacturers, both local and established ones, to increasingly distribute their products via online channels. For instance, this trend has encouraged many new entrants and existing companies such as 24Bottles, The Friendly Cup, and United Bottles to drive up sales using online traction.

With a fine blend of technological innovation and customization, the market is exploring new aspects of product development. For instance, in 2018, LARQ launched the world’s first self-cleaning water bottle as well as the largest crowdfunded effort for a clean water initiative, with over USD 1.7 million raised in funding. The company witnessed a 400% increase in revenue year-on-year in 2020 and an 80% increase in conversion rate in 3 months.

Request a free sample copy or view report summary: Europe Reusable Water Bottle Market Report

Europe Reusable Water Bottle Market Report Highlights

• By material, the steel segment is projected to expand at the fastest revenue-based CAGR of 5.0% from 2021 to 2028
• By type, the non-insulated segment accounted for the largest revenue share of over 77.0% in 2020 and is expected to maintain its lead in the years to come
• Germany held the largest revenue share of 28.7% in 2020 and is foreseen to remain at the forefront over the forecast period

Access Press Release@ https://www.grandviewresearch.com/press-release/europe-reusable-water-bottle-market-analysis

Europe Reusable Water Bottle Market Segmentation

Grand View Research has segmented the Europe reusable water bottle market on the basis of material, type, distribution channel, and country:

Europe Reusable Water Bottle Material Outlook (Volume, Million Units; Revenue, USD Million, 2016 - 2028)

• Glass
• Aluminum
• Plastic
• Silicone
• Steel
• Others (Copper, Brass)

Europe Reusable Water Bottle Type Outlook (Volume, Million Units; Revenue, USD Million, 2016 - 2028)

• Insulated
• Non-insulated

Europe Reusable Water Bottle Distribution Channel Outlook (Volume, Million Units; Revenue, USD Million, 2016 - 2028)

• Online
• Offline
  • Wholesale
  • Supermarkets/Hypermarkets
  • Specialty Stores
  • Sport Stores
  • Local Stores

Europe Reusable Water Bottle Country Outlook (Volume, Million Units; Revenue, USD Million, 2016 - 2028)

• Germany
• Austria
• Switzerland
• France
• Great Britain
• Spain
• Italy

List of Key Players of Europe Reusable Water Bottle Market:

• Tupperware Brands Corporation
• SIGG Switzerland Bottles AG
• Hydaway
• 24 Bottles
• Hydro Flask
• Klean Kanteen
• Contigo
• CamelBak Products, LLC
• Laken
• Ball Corporation
• Thermos L.L.C.
• S’well
• Chilly’s Bottles Limited

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Animal Wound Care Market to Expand at a CAGR of 6.4% Through 2028: Grand View Research Inc.

 Animal Wound Care Market Growth & Trends

The global animal wound care market size is expected to reach USD 1.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.4% from 2021 to 2028. Increased demand for non-invasive surgeries and the growing prevalence of chronic diseases are propelling the growth. Increasing disposable income in developing countries is expected to further fuel the market. According to Aratana therapeutics report, around 25 million dogs had undergone surgeries in the U.S. in 2019 and among them, around 5.5 million suffered from postoperative pain.

Like other industries, the animal health industry has also been significantly affected in COVID -19 due to the slow movement of the small businesses, service providers, and consumers paused to the social distancing norms and other restrictions. In many countries, the impact of COVID-19 was amplified through other occurrences, such as the African swine fever in Europe and wildfires in the western USA. After the initial shock and confusion about the pandemic, companies and governments soon started taking corrective actions to help the economy and businesses recover. Resumption of pet clinic visits also observed during the 3^rd quarter of 2020, thus gradually recovering the revenue.

Increasing initiatives by the major industry players are further propelling the market. For instance, in July 2019, Vetoquinol launched an antibiotic dressing spray in India to expand its geographical footprint. In March 2021, AxioBiosolutions expanded its animal wound management space with the introduction of the SureKlot range of products.

Request a free sample copy or view report summary: Animal Wound Care Market Report

Animal Wound Care Market Report Highlights

• The surgical wound care products segment dominated the market and accounted for the largest revenue share in 2020. This contribution is mainly because of the increased number of veterinary surgeries and rising demand for advanced care products
• The companion animal segment dominated the market and accounted for the largest revenue share of 64.0% in 2020. The increasing companion animal population and growing incidences of chronic diseases are boosting segment growth
• The home care segment is expected to exhibit the fastest growth rate during the study period. The key factors attributing to the growth of the segment are increasing awareness among pet parents and the availability of advanced care products via the e-commerce channel
• The veterinary hospitals/clinics segment held the largest revenue share in 2020. The growth can be attributed to increased patient foot-fall and advanced treatment options
• North American dominated the market and accounted for the largest revenue share in 2020. The rising implementation of regulatory standards and reimbursement policies along with the high adoption rate of companion animals are anticipated to contribute to market growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-animal-wound-care-market

Animal Wound Care Market Segmentation

Grand View Research has segmented the global animal wound care market on the basis of product, animal type, end-user, distribution channel, and region:

Animal Wound Care Product Outlook (Revenue, USD Million, 2016 - 2028)

• Surgical Wound Care Products
  • Sutures and Staplers
  • Tissue Adhesives, Sealants, And Glues
• Advanced Wound Care Products
  • Foam Dressings
  • Hydrocolloid Dressings
  • Film Dressings
  • Hydrogel Dressings
  • Other Advanced Dressings
• Traditional Wound Care Products
  • Tapes
  • Dressings
  • Bandages
  • Absorbents
  • Other Traditional Wound Care Products
• Therapy Devices

Animal Wound Care Animal Type Outlook (Revenue, USD Million, 2016 - 2028)

• Companion Animal
  • Cats
  • Dogs
  • Horses
  • Others
• Livestock Animal

Animal Wound Care End-user Outlook (Revenue, USD Million, 2016 - 2028)

• Veterinary Hospitals & Clinics
• Homecare
• Research Institutes

Animal Wound Care Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Retail
• E-commerce
• Veterinary Hospitals & Clinics

Animal Wound Care Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Animal Wound Care Market

• Braun Melsungen AG
• Medtronic
• 3M Company
• Johnson & Johnson (Ethicon)
• Virbac
• Advancis Veterinary Ltd
• Innovacyn, Inc.
• Robinson Healthcare
• NEOGEN Corporation
• KeriCure, Inc.
• Sonoma Pharmaceuticals, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Demand for Laparoscopic Power Morcellators Market to Incur Considerable Upsurge During 2021 – 2028: Grand View Research Inc.

 Laparoscopic Power Morcellators Market Growth & Trends

The global laparoscopic power morcellators market size is anticipated to reach USD 188.7 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.4% from 2021 to 2028. The increasing number of patients suffering from health issues such as uterine fibroids and endometriosis and the rising number of hysterectomy and myomectomy procedures is expected to drive the demand for laparoscopic power morcellators.

The COVID-19 outbreak has led to the global implementation of strict measures to curb the spread, which has led to a drastic cancellation or halt of elective surgeries including hysterectomy and myomectomy procedures worldwide. During this time, a large number of medical device manufacturing facilities, global suppliers, and distributors have been adversely affected in several regions. However, with the abundance of postponed surgical procedures in the pipeline, the market is expected to rebound and grow significantly over the forecast period.

The prevalence of uterine fibroids in women is on the rise across the globe and this can lead to excessive menstrual bleeding, pelvic pain, infertility, and frequent urination. As per the U.S. National Institutes of Health (NIH), 20-25% of women of reproductive age have fibroids and by the age of 50, up to 80% of black women and up to 70% of white women have fibroids. Thus, the rising prevalence of uterine fibroids is increasing the demand for myomectomy and hysterectomy procedures, thereby contributing to market growth.

Moreover, growing patient preference for minimally invasive treatments is expected to strengthen the growth of the market. Larger fibroids can be removed through minor incisions by breaking them into pieces through a technique called morcellation, with the help of laparoscopic power morcellators. It is a less invasive procedure and causes less discomfort and post-operative pain. This is expected to boost the market growth at a significant rate during the forecast period.

Request a free sample copy or view report summary: Laparoscopic Power Morcellators Market Report

Laparoscopic Power Morcellators Market Report Highlights

• Based on application, the hysterectomy segment dominated the market and accounted for the largest revenue share of 70.5% in 2020, owing to the increasing number of surgeries to treat uterine fibroid. For instance, in the U.S. every year, around 600,000 women go for a hysterectomy to get relief from troubling fibroid symptoms
• North America dominated the market and accounted for the largest revenue share of 52.8% in 2020 owing to increasing fibroids related surgical procedures/hospital visits as well as the availability of the latest treatment procedures in the region
• In the Asia Pacific, the market is expected to witness the highest CAGR over the forecast period owing to improving health spending and rising awareness regarding health among women in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-laparoscopic-power-morcellators-market

Laparoscopic Power Morcellators Market Segmentation

Grand View Research has segmented the global laparoscopic power morcellators market on the basis of application and region:

Laparoscopic Power Morcellators Application Outlook (Revenue, USD Million, 2016 - 2028)

• Hysterectomy
• Myomectomy
• Others

Laparoscopic Power Morcellators Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Laparoscopic Power Morcellators Market

• Medtronic
• Karl Storz GmbH
• Richard Wolf GmbH
• LiNA Medical
• Lumenis (Boston Scientific Corporation)
• Nouvag AG
• Olympus Corporation
• RUDOLF Medical GmbH

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

PPG Biosensors Market To Benefit from Increased Global Uptake of 2021 to 2028

 PPG Biosensors Market Growth & Trends

The global PPG biosensors market size is expected to reach USD 839.3 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.1% from 2021 to 2028. An increasing number of cardiovascular disorders, the impact of COVID-19, the surge in adoption of smart wearables, and technological advancements are the key driving factors for the market.

The increasing incidence of cardiovascular diseases across the globe is anticipated to drive the market. For instance, according to the American Heart Association, almost 17.0 million people die each year as a result of cardiac abnormalities, and this figure is expected to rise to 23 million by 2030. PPG typically measures blood pressure, oxygen saturation, and cardiac output through a series of waves and peak detection. Thus, the rising number of CVDs is expected to boost the demand for PPG biosensors, which is expected to lead to considerable market growth over the forecast period.

The increasing adoption of wearable healthcare devices in developing economies is expected to drive the market. Fit bits, pulse oximeters, smartwatches, and other wearable healthcare systems are incorporated with optical sensors to provide real-time patient health tracking solutions. For instance, the Realme watch comes with wide-ranging health functions comprising of blood-oxygen-level (SpO2) and top-level PPG heart rate sensors. Several smartwatches with inbuilt PPG sensors from Apple, Moto G, Realme will be launching in later 2021. In Oct 2020, Mobvoi launched its new TicWatch Pro 3 smartwatch in India that consists of a PPG sensor. Moreover, smart rings are relatively new, however, Oura Ring facilitated with Infrared Photoplethysmography Sensors (PPG) for heart rate and respiration, is booming in the market. These sensors have many advantages, including high precision, small scale, and no sensitivity to electromagnetic radiation, which makes them suitable for use in medical-grade wearable devices.

Request a free sample copy or view report summary: PPG Biosensors Market Report

PPG Biosensors Market Report Highlights

• In terms of revenue, the smartwatches segment held the largest revenue share in 2020. The rising adoption of smartwatches across the globe is the major factor propelling the segment growth
• The heart rate monitoring segment held the largest revenue share in 2020 and is expected to witness the fastest growth over the forecast period due to the increasing number of cardiovascular disorders
• In Asia Pacific, the market is expected to witness the fastest growth rate over the forecast period owing to the rising prevalence of cardiovascular disorders

Access Press Release@ https://www.grandviewresearch.com/press-release/global-ppg-biosensors-market

PPG Biosensors Market Segmentation

Grand View Research has segmented the global PPG biosensors market on the basis of product, application, and region:

PPG Biosensors Product Outlook (Revenue, USD Million, 2016 - 2028)

• Pulse Oximeters
• Smart Watches
• Smart Wrist Bands
• Other Products

PPG Biosensors Application Outlook (Revenue, USD Million, 2016 - 2028)

• Heart Rate Monitoring
• Blood-oxygen Saturation
• Blood Pressure
• Other Applications

PPG Biosensors Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of PPG Biosensors Market

• Valencell, Inc.
• Maxim Integrated
• Murata Manufacturing Co., Ltd.
• Silicon Laboratories
• Mediatek
• ams AG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

COVID-19 Saliva Screening Test Potential Market Size, Industry Share And Growth Analysis For 2021-2023: Grand View Research Inc.

 COVID-19 Saliva Screening Test Potential Market Growth & Trends

The global COVID-19 saliva screening test potential market size is expected to reach USD 3,406.2 billion by 2023, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 4.8% from 2021 to 2023. The rise in demand for rapid, efficient, saliva-based screening tests has positively impacted market growth.

This is primarily due to the various advantages offered by saliva-based tests, increasing product approvals by regulatory bodies, and a paradigm shift toward point-of-care testing. The fluorescence-labeled antigen/antibodies test is one of the recent saliva-based COVID-19 screening tests in the market which is based on the principles of fluorescence detection, biochemistry, robotics automation, and cloud computing.

As the number of people visiting public places is increasing and reaching pre-pandemic statistics in a few countries, there is a growing demand for rapid, point-of-care COVID-19 tests to mitigate viral transmission from asymptomatic people. This has enhanced the R&D for the development of simple yet effective saliva-based tests and is expected to create lucrative opportunities for several developers.

Request a free sample copy or view report summary: COVID-19 Saliva Screening Test Potential Market Report

COVID-19 Saliva Screening Test Potential Market Report Highlights

• The market estimates represent a potential market size for the COVID-19 saliva screening test based on the assumptions that the end-use locations have a 60% population attendance or capacity (60% of pre-COVID attendance) and the testing rate using test device is 100%
• Saliva-based tests play a vital role in screening asymptomatic individuals thereby aiding in market revenue generation in the near future
• The fluorescence-labeled antigen/antibodies test is designed to accelerate rapid point-of-access testing of individuals
• Owing to the pandemic, the economy across the various sectors is severely impacted.
• However, with the reopening of various sectors and locations such as shopping malls and amusement parks, there is a growing need for screening individuals to curb viral transmission
• In the U.S., more than 40 amusement parks have prepared to reopen by the spring of 2021, thus increasing the demand for rapid tests
• Thus, there is a high growth potential for the market with the increase in usage of the medical test at various locations to screen individuals
• Regulatory bodies such as the U.S. FDA and European Medicine Agency (EMA) have supported these products by providing EUA and product approvals
• In April 2021, Vatic Health received the CE mark for its on-the-spot’ saliva antigen test for the SARS-CoV-2 virus. The test has also completed the Medicines and Healthcare Products Regulatory Agency (MHRA) registration in the U.K.
• North America dominated the market owing to the high penetration and adoption of saliva-based screening tests in the region
• The U.S. is the major contributor to revenue generation due to the emergence of new small and mid-sized companies engaged in the development of such tests

Access Press Release@ https://www.grandviewresearch.com/press-release/global-covid-19-saliva-screening-test-potential-market

COVID-19 Saliva Screening Test Potential Market Segmentation

Grand View Research has segmented the global COVID-19 saliva screening test potential market on the basis of location, technology, mode, and region:

COVID-19 Saliva Screening Test Potential Location Outlook (North America) (Revenue, USD Million, 2020 - 2023)

• Travel Stations
  • Airports
  • Cruise
  • Ports
  • Train Stations
  • Border Crossing
• Sports Arenas
• Concert Halls
• Shopping Malls and Centers
• Amusement Parks
• Corporate Campus Environments
• Universities & Colleges
• Factories
  • Food Processing Plants
  • Meat Packing Plants
  • Pharmaceutical Plants
  • Mining
  • Retail Working Warehouses

COVID-19 Saliva Screening Test Potential Location Outlook (Other Regions) (Revenue, USD Million, 2020 - 2023)

• Travel Stations
• Sports Arenas
• Entertainment Venues
• Corporate Campus Environments
• Universities & Colleges
• Factories

COVID-19 Saliva Screening Test Potential Technology Outlook (Revenue, USD Million, 2020 - 2023)

• Fluorescence-labeled antigen/antibodies testing
• RT-PCR
• CRISPR-Cas9

COVID-19 Saliva Screening Test Potential Mode Outlook (Revenue, USD Million, 2020 - 2023)

• Centralized Testing
• Decentralized Testing

COVID-19 Saliva Screening Test Potential Regional Outlook (Revenue, USD Million, 2020 - 2023)

• North America
  • US.
  • Canada
• Europe
• Asia Pacific
• Rest of World

List of Key Players in COVID-19 Saliva Screening Test Potential Market

• FluroTech Ltd.
• ARUP Laboratories
• Vatic Health
• MOgene
• Psomagen Inc.
• DxTerity Diagnostics, Inc.
• Ambry Genetics
• Fluidigm Corporation
• Phosphorus Diagnostics LLC
• Gravity Diagnostics
• DNA Genotek, Inc.
• Quidel Corporation
• Abbott
• LumiraDX

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Veterinary Oncology Market Size Is Expected To Reach USD 143.2 Million by 2028

 U.S. Veterinary Oncology Market Growth & Trends

The U.S. veterinary oncology market size is expected to reach USD 143.2 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.4% from 2021 to 2028. The increasing prevalence of cancer in pets, willingness to spend on them by pet owners, and use of canine as a model for clinical trials by researchers are the key contributing factor towards this segment growth. In addition, an increase in the incidence of cancer in the feline population and rising pet ownership resulting in the increased focus on pet health is further expected to spur the growth.

Moreover, companies operating in the market are increasingly adopting strategies, such as mergers and acquisitions, research agreements, collaboration, partnerships, geographic expansion, and product development to enhance their position in the market. For instance, in November 2020, Virbac publicized the approval of Stelfonta, a novel intratumoral injection treatment for canine mast cell tumors. In addition, Elanco purchased Aratana Therapeutics for its pet products pipeline. The company also had an agreement to create rabacfosadine (Tanovea), a drug from VetDC. The drug also had received U.S. FDA approval for treating lymphoma in dogs. Hence, the market is expected to witness intense competition over the forecast period.

Clinical trials are a critical aspect of veterinary oncology. The accelerated number of clinical research involving surgical procedures in pets is further fueling the market growth. For instance, in May 2019, Oregon State University conducted a research study stating that the risk of cancer recurrence reduced to 60% in dogs whose tumors were completely resected. With the growing number of pet parents in the U.S., animal health awareness is rising amongst people. In the U.S. there are various pet health awareness events such as National Pet Week are conducted to create awareness.

The risk of animals spreading COVID-19 to individuals is considered to be little. The FDA is alert that the COVID-19 pandemic may influence ongoing studies being conducted to provision new animal drug development. Thereby, issued guidelines in April 2020 to help to diminish the potential impact of the pandemic on new animal drug development.

Request a free sample copy or view report summary: U.S. Veterinary Oncology Market Report

U.S. Veterinary Oncology Market Report Highlights

• The radiology segment is expected to dominate the market. Factors such as increasing government initiatives to the establishment of new veterinary radiation centers and advancements in radiation technology are expected to boost demand for the radiation therapy segment
• The immunotherapy segment is expected to witness a CAGR of 8.9% owing to the growing number of veterinary centers focused on carrying out clinical trials in immunotherapy areas
• The chemotherapy segment is the second-largest segment of the market. According to Cancer Veterinary Center, the most common canine and feline tumors treated with chemotherapy are osteosarcomas, lymphomas, hemangiosarcoma, mast cell tumors, bladder tumors, and mammary gland tumors
• The canine segment emerged as the largest revenue-generating segment of the market in 2020. The rising incidence of cancer in canines and ongoing product innovations in this domain is the key growth contributors

Access Press Release@ https://www.grandviewresearch.com/press-release/us-veterinary-oncology-market-analysis

U.S. Veterinary Oncology Market Segmentation

Grand View Research has segmented the U.S. veterinary oncology market on the basis of therapy and animal type:

U.S. Veterinary Oncology Therapy Outlook (Revenue, USD Million, 2016 - 2028)

• Surgery
• Radiology
  • Stereotactic Radiation Therapy
    • Gamma Knife
    • LINAC
    • PBRT
    • CyberKnife
  • Brachytherapy
  • Others
• Chemotherapy
• Immunotherapy
• Others

U.S. Veterinary Oncology Animal Type Outlook (Revenue, USD Million, 2016 - 2028)

• Canine
  • Lymphoma
  • Mast cell cancer
  • Mammary and Squamous cell cancer
  • Others
• Feline
  • Mammary and Squamous cell cancer
  • Others
• Others

List of Key Players of U.S. Veterinary Oncology Market

• Boehringer Ingelheim International GmbH
• Elanco
• Zoetis
• PetCure Oncology
• Accuray Incorporated
• Varian Medical System, Inc.
• Morphogenesis, Inc.
• Karyopharm Therapeutics, Inc.
• Regeneus Ltd.
• One Health

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cell And Gene Therapy Clinical Trials Market Size Is Expected To Reach USD 45.4 Billion by 2028

 Cell And Gene Therapy Clinical Trials Market Growth & Trends

The global cell and gene therapy clinical trials market size is expected to reach USD 45.4 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 22.3% from 2021 to 2028. Increasing funding, investments in research and development, and successful product launches are boosting the market growth.

Cell and gene therapies (CGTs) signify the next great movement of therapeutic innovation and have resulted in the development of promising therapies around the world. Although a few of the early therapies have got marketing approval in the U.S., there are numerous promising therapies in development across the world.

The market of cell and gene therapy has witnessed significant growth over the past few years with pharma firms partnering to create effective and accessible therapies for patients. As reported by PhRMA in 2019, there were 362 cell and gene therapies in clinical development in the U.S. representing a 20% increase from 2018. In addition, by the end of 2019, there were more than 1,000 cell and gene therapy clinical trials in the process including 452 gene-modified and cell-based immune-oncology, 352 gene therapies, 216 cell therapies, and 46 tissue engineering.

Besides, investment is rolling into companies of various types, ranging from startups to major acquisitions by significant biopharmaceutical companies. In 2019, 19 deals of M&A worth over USD 156 billion were completed. The largest of these was the acquisition of Celgene and its pipeline of numerous cell therapy assets by Bristol-Myers Squibb for USD 74 billion is expected to boost its participation in oncology treatments. Hence, representing a noteworthy increase since 2015, when M&A activities in these are totaled about USD 4 billion.

Request a free sample copy or view report summary: Cell And Gene Therapy Clinical Trials Market Report

Cell And Gene Therapy Clinical Trials Market Report Highlights

• By phase, the phase II segment held the largest share of over 50.0% in 2020 owing to the large number of therapies currently in development in phase II
• Based on indication, the oncology segment held the largest share of 47.0% in 2020 as oncology alone contributed to 600 CGT clinical trials out of around 1,000
• North America dominated the global market with a share of 48.3% in 2020. This is largely attributed to a large number of clinical trial activities in the U.S. and favorable government support
• The Asia Pacific region is expected to expand at the fastest CAGR of 23.1% over the forecast period owing to the increasing number of biotechnology companies focusing on CGTs

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cell-gene-therapy-clinical-trials-market

CGT Clinical Trials Market Segmentation

Grand View Research has segmented the global cell and gene therapy clinical trials market based on phase, indication, and region:

CGT Clinical Trials Phase Outlook (Revenue, USD Million, 2016 - 2028)

• Phase I
• Phase II
• Phase III
• Phase IV

CGT Clinical Trials Indication Outlook (Revenue, USD Million, 2016 - 2028)

• Oncology
• Cardiology
• CNS
• Musculoskeletal
• Infectious diseases
• Dermatology
• Endocrine, metabolic, genetic
• Immunology & inflammation
• Ophthalmology
• Hematology
• Gastroenterology
• Others

CGT Clinical Trials Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • India
  • Japan
  • China
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Cell And Gene Therapy (CGT) Clinical Trials Market

• IQVIA
• ICON Plc
• Covance
• Charles River Laboratory
• PAREXEL International Corporation
• Syneos Health
• Medpace Holdings, Inc.
• Novartis
• Novotech
• Veristat, LLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.